IVF FAQs

In vitro fertilization (IVF) is an assisted reproductive treatment in which eggs are collected from the ovaries and fertilized with sperm in a laboratory. An embryo may then be transferred into the uterus.

IVF stands for in vitro fertilization. “In vitro” means that fertilization takes place outside the body, in a laboratory setting.

IVF may be considered for blocked or damaged fallopian tubes, certain cases of male-factor infertility, endometriosis, ovulation-related problems, unexplained infertility, or when other treatments have not resulted in pregnancy. The decision depends on individual assessment.

No. IVF is one of several fertility treatment options. Depending on the cause of infertility, a person or couple may be offered medication, surgery, IUI, IVF, or another approach after evaluation.

In IUI, prepared sperm is placed inside the uterus around ovulation, and fertilization occurs inside the body. In IVF, eggs are collected and fertilized in a laboratory before an embryo is transferred into the uterus.

ICSI is a fertilization technique used during IVF. In conventional IVF, eggs and sperm are placed together in a laboratory dish. In ICSI, an embryologist injects a single sperm directly into an egg.

Yes. IVF, sometimes combined with ICSI, may be used for certain male-factor infertility conditions. The appropriate approach depends on semen results, medical history, and any additional investigations.

IVF can bypass the fallopian tubes because fertilization occurs in the laboratory. It may therefore be considered when the tubes are blocked or severely damaged.

IVF may be an option for some couples with unexplained infertility, particularly when pregnancy has not occurred after other appropriate management. The decision should consider age, duration of infertility, previous treatment, and individual preferences.

Yes. IVF may be considered for people with PCOS when clinically appropriate. Ovarian stimulation requires individualized planning because some patients with PCOS have an increased risk of an excessive ovarian response.

Assessment may include medical and reproductive history, ultrasound, hormone tests, ovarian reserve assessment, semen analysis, and screening tests. Additional investigations may be recommended according to the patient’s history and clinical findings.

AMH, or anti-Müllerian hormone, is commonly used as one indicator of ovarian reserve and can help guide stimulation planning. It does not independently measure egg quality or guarantee pregnancy.

A semen analysis is an important part of fertility assessment. It evaluates parameters such as sperm concentration, motility, morphology, and semen volume, and may help determine whether ICSI or other measures should be considered.

Not necessarily. People with irregular or absent periods may still be candidates for IVF. The fertility specialist will investigate the cause and plan treatment accordingly.

Yes. Age, particularly the age of the person providing the eggs, is an important factor affecting IVF outcomes. Ovarian reserve, embryo development, medical history, and other factors also contribute.

Preparation may include completing recommended investigations, reviewing medications and medical conditions, avoiding tobacco, limiting or avoiding alcohol, following a balanced diet, and taking prescribed supplements such as folic acid when advised. Follow the clinic’s individualized instructions.

When possible, involving both partners can help the specialist review the couple’s reproductive history, investigations, treatment choices, and questions together. Separate consultations may also be arranged when appropriate.

IVF may still be considered in some people with diminished ovarian reserve. The expected response and likely outcomes vary, so counselling should be based on age, test results, previous response, and the complete clinical picture.

No. Genetic testing is not automatically required for every IVF cycle. Carrier screening, preimplantation genetic testing, or other genetic investigations may be discussed when indicated by medical history, family history, or specific clinical circumstances.

Yes. IVF may be considered after unsuccessful treatment, but the next step depends on the previous treatment, diagnosis, age, investigations, and patient preferences. The specialist may review the earlier records before recommending a plan.

IVF commonly involves ovarian stimulation, ultrasound and/or blood-test monitoring, egg retrieval, fertilization in the laboratory, embryo culture, embryo transfer or freezing, and pregnancy testing. The exact protocol varies by patient.

The active treatment portion of an IVF cycle often takes several weeks, but the overall timeline can be longer if preliminary investigations, treatment of medical conditions, embryo freezing, or a later frozen embryo transfer is required.

Fertility medications are used to encourage the ovaries to develop multiple follicles. The response is monitored, commonly with ultrasound and sometimes blood tests, so the treatment team can adjust the plan when needed.

Many stimulation injections are given under the skin and may cause temporary discomfort, bruising, or irritation. Experiences vary. The clinical team can explain the injection technique and how to manage common local effects.

Egg retrieval is a procedure in which eggs are collected from ovarian follicles, usually with ultrasound guidance and sedation or anaesthesia. The clinic provides instructions about preparation, fasting, transport, and recovery.

Egg retrieval is generally a short, minimally invasive procedure, commonly performed through the vagina under ultrasound guidance. It still carries risks, and patients should follow the clinic’s instructions and discuss their individual medical suitability.

The eggs are assessed in the laboratory and fertilization is attempted using the planned method. Embryos are then monitored as they develop, and the team discusses whether transfer or freezing is appropriate.

Embryo culture is the period during which fertilized eggs are maintained and monitored in specialized laboratory conditions as they develop. Embryos may be assessed at different developmental stages according to the laboratory’s protocol.

A blastocyst is an embryo at a later stage of development, commonly reached around day five or six after fertilization, although development timing can vary. Some IVF cycles involve transfer or freezing at the blastocyst stage.

Embryo transfer is the placement of an embryo into the uterus using a thin catheter. It is usually performed through the cervix and generally does not require an abdominal incision.

Many patients experience little discomfort, although mild cramping or pressure can occur. Individual experiences vary, and the clinic can explain what to expect during and after the procedure.

A frozen embryo transfer involves thawing a previously cryopreserved embryo and transferring it into the uterus in a later cycle. The uterine lining and timing are prepared and monitored according to the treatment protocol.

A fresh embryo transfer takes place during the same treatment cycle in which the eggs were collected and fertilized. Whether fresh transfer is appropriate depends on clinical factors and the planned treatment strategy.

The number depends on factors such as age, embryo characteristics, previous treatment history, and applicable clinical guidance. Transferring more embryos can increase the risk of multiple pregnancy, so the plan should be individualized.

Yes. Suitable embryos may be cryopreserved for possible future transfer, subject to laboratory assessment, clinical advice, consent, and applicable regulations.

IVF success rates vary with age, diagnosis, ovarian reserve, embryo development, treatment history, and the outcome being measured. Ask the clinic for clearly defined, age-specific results relevant to your circumstances; no outcome can be guaranteed.

No. IVF does not guarantee pregnancy, and some cycles may not result in embryo transfer or pregnancy. A specialist can review the outcome and discuss whether further treatment or a different approach may be appropriate.

Potential risks include medication side effects, ovarian hyperstimulation syndrome (OHSS), bleeding or infection related to egg retrieval, complications associated with sedation, ectopic pregnancy, and multiple pregnancy. The likelihood varies by patient and treatment plan.

OHSS is a complication in which the ovaries respond excessively to fertility medication, potentially causing enlarged ovaries and fluid shifts. Symptoms can range from mild bloating to serious illness. Contact the treatment team promptly if concerning symptoms develop.

Prolonged bed rest is not routinely required after an uncomplicated embryo transfer. Follow the clinic’s specific advice about activity, medications, and any restrictions related to your individual circumstances.

Many people can return to usual, non-strenuous activities after embryo transfer, depending on how they feel and the clinic’s advice. Ask your treatment team about work, exercise, travel, and any activity restrictions relevant to your cycle.

The clinic schedules a pregnancy test at an appropriate interval after transfer, often using a blood test for beta-hCG. Testing too early or interpreting home tests without guidance may be misleading, so follow the clinic’s date and instructions.

The fertility team will advise whether and when to stop medications, review the cycle, and discuss possible next steps. Options depend on the treatment outcome, available embryos, medical findings, and the patient’s preferences.

Yes. Multiple pregnancy can occur, particularly when more than one embryo is transferred. The risks of multiple pregnancy should be discussed with the specialist, and embryo-transfer planning should follow appropriate clinical guidance.

Many children conceived through IVF are healthy. As with any pregnancy, outcomes depend on several factors, including parental health, underlying infertility, pregnancy complications, and other individual circumstances.

IVF costs vary by clinic, location, treatment protocol, medications, laboratory procedures, and whether additional services are needed. Request a written estimate that explains what is included and what may incur extra charges.

Coverage depends on the insurance policy, provider, location, and applicable rules. Check directly with your insurer and clinic to clarify eligibility, exclusions, documentation, and reimbursement procedures.

Some patients may consider another IVF cycle after reviewing the previous outcome with their specialist. The decision should account for the cause of infertility, age, response to medication, embryo results, medical risks, finances, and personal preferences.

IVF can be emotionally demanding. Open communication, realistic expectations, support from trusted people, counselling, and asking the clinic about available emotional support may help. Seek professional support if distress becomes difficult to manage.

Consider asking about your diagnosis, recommended treatment and alternatives, age-specific success rates and how they are calculated, medication and procedure risks, embryo-transfer strategy, likely timeline, total costs, laboratory practices, and available counselling or support.